National Institutes of Health: “Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.”
Federation of State Medical Boards: “Joint Statement of FSMB, NABP, NCSBN on Inappropriate Prescribing and Dispensing of Medications During the COVID-19 Pandemic.”
Arthur Caplan, PhD, bioethicist, New York University.
Jeremy Kahn, spokesperson, FDA.
Steve Rye, CEO, Mercola Health Resources LLC.
Peter Lurie, MD, president and executive director, Center for Science in the Public Interest.
Senate Committee on Commerce, Science and Transportation Subcommittee on Manufacturing, Trade and Consumer Protection hearing, and testimony of Laura MacCleery, policy director of Center for Science in the Public Interest, July 21, 2020.
Humayun Chaudhry, DO, president and chief executive officer, Federation of State Medical Boards.
Carlos Villatoro, spokesperson, Medical Board of California, Sacramento.
Mitchell Katz, spokesperson, FTC.
News release, Center for Science in the Public Interest: “FDA and FTC Urged to Bring Enforcement Proceedings Against Joseph Mercola for False COVID-19 Health Claims.”
Medical Board of California.
News release: “FTC Testifies Before Congress on Efforts to Combat COVID-19-related Scams.”
News release, U.S. Attorney’s Office, Southern District of California: “Carmel Valley Physician Charged with Fraud for Selling Purported COVID-19 ‘Miracle Cure.”’
FDA: “Fraudulent Coronavirus Disease 2019 (COVID-19) Products.”